Phase I safety and immunogenicity testing of clinical lots of the synthetic Plasmodium falciparum vaccine SPf66 produced under good manufacturing procedure conditions in the United States.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples